KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Ionis Pharmaceuticals (IONS) Accumulated Depreciation & Amortization: 2014-2024

  • Ionis Pharmaceuticals' Accumulated Depreciation & Amortization rose 10.84% to $97.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $344.7 million, marking a year-over-year increase of 10.74%. This contributed to the annual value of $97.7 million for FY2024, which is 10.84% up from last year.
  • As of Q4 2024, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization stood at $97.7 million, which was up 10.84% from $88.2 million recorded in Q4 2023.
  • In the past 5 years, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $97.7 million during Q4 2024, and its lowest value of $64.3 million during Q4 2020.
  • For the 3-year period, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $88.4 million, with its median value being $88.2 million (2023).
  • Per our database at Business Quant, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization climbed by 26.23% in 2020 and then fell by 0.56% in 2022.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Accumulated Depreciation & Amortization stood at $64.3 million in 2020, then increased by 23.75% to $79.6 million in 2021, then dropped by 0.56% to $79.1 million in 2022, then climbed by 11.43% to $88.2 million in 2023, then climbed by 10.84% to $97.7 million in 2024.
  • Its last three reported values are $97.7 million in Q4 2024, $88.2 million for Q4 2023, and $79.1 million during Q4 2022.